{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:53:03Z","timestamp":1793418783143,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ajog.2015.12.038","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T03:17:03Z","timestamp":1450840623000},"page":"720.e1-720.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":231,"title":["Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial"],"prefix":"10.1016","volume":"214","author":[{"given":"Maged M.","family":"Costantine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud S.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Easterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Haneline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve N.","family":"Caritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Venkataramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"D\u2019Alton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Hankins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.12.038_bib1","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.038_bib2","doi-asserted-by":"crossref","first-page":"c72","DOI":"10.1159\/000101801","article-title":"Preeclampsia: clinical manifestations and molecular mechanisms","volume":"106","author":"Baumwell","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ajog.2015.12.038_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/HYPERTENSIONAHA.110.150078","article-title":"Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort","volume":"56","author":"Mongraw-Chaffin","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2015.12.038_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/AOG.0b013e3181801d56","article-title":"Prediction and prevention of recurrent preeclampsia","volume":"112","author":"Barton","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.038_bib5","doi-asserted-by":"crossref","first-page":"b2255","DOI":"10.1136\/bmj.b2255","article-title":"Risk\u00a0of pre-eclampsia in first and subsequent pregnancies: prospective cohort study","volume":"338","author":"Hern\u00e1ndez-D\u0131az","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2015.12.038_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-pathol-121808-102149","article-title":"Pathogenesis of preeclampsia","volume":"5","author":"Young","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajog.2015.12.038_bib7","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1042\/BST20110672","article-title":"Is inflammation the cause of preeclampsia?","volume":"39","author":"Ramma","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.ajog.2015.12.038_bib8","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.12.038_bib9","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2015.12.038_bib10","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.jacc.2008.08.039","article-title":"Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients","volume":"52","author":"Mills","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ajog.2015.12.038_bib11","doi-asserted-by":"crossref","first-page":"b2376","DOI":"10.1136\/bmj.b2376","article-title":"The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials","volume":"338","author":"Brugts","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2015.12.038_bib12","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.106.660134","article-title":"Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1","volume":"115","author":"Cudmore","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2015.12.038_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/AOG.0b013e3181e10ebd","article-title":"Using pravastatin to improve the vascular reactivity in a mouse model of soluble Fms-like tyrosine kinase-1-induced preeclampsia","volume":"116","author":"Costantine","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.038_bib14","doi-asserted-by":"crossref","first-page":"366.e1","DOI":"10.1016\/j.ajog.2011.06.083","article-title":"Effects of\u00a0pravastatin on mediators of vascular function in a mouse model of soluble Fms-like tyrosine kinase-1\u2013induced preeclampsia","volume":"205","author":"Fox","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.038_bib15","doi-asserted-by":"crossref","first-page":"e13663","DOI":"10.1371\/journal.pone.0013663","article-title":"A\u00a0new mouse model to explore therapies for preeclampsia","volume":"10","author":"Ahmed","year":"2010","journal-title":"PLoS One 5"},{"key":"10.1016\/j.ajog.2015.12.038_bib16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1161\/HYPERTENSIONAHA.111.175919","article-title":"Role of complement component C1q in the onset of preeclampsia in mice","volume":"58","author":"Singh","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2015.12.038_bib17","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ajog.2015.12.038_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1933719113492207","article-title":"Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia","volume":"21","author":"Saad","year":"2014","journal-title":"Rep Sci"},{"key":"10.1016\/j.ajog.2015.12.038_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/AOG.0b013e31827d8ad5","article-title":"Pravastatin for the prevention of preeclampsia in high risk pregnant women","volume":"121","author":"Costantine","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.038_bib20","first-page":"159","article-title":"Diagnosis and management of\u00a0preeclampsia and eclampsia. ACOG Practice bulletin","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.038_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.30386","article-title":"Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins","volume":"131A","author":"Edison","year":"2004","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajog.2015.12.038_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2125.2007.02905.x","article-title":"Risk of congenital anomalies in pregnant users of statin drugs","volume":"64","author":"Ofori","year":"2007","journal-title":"Br J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ajog.2015.12.038_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.reprotox.2008.06.009","article-title":"Prenatal exposure to HMG-CoA reductase inhibitor: effects on fetal and neonatal outcomes","volume":"26","author":"Taguchi","year":"2008","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2015.12.038_bib24","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/ajmg.a.32493","article-title":"Maternal exposure to statins and risk for birth\u00a0defects","volume":"146A","author":"Petersen","year":"2008","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajog.2015.12.038_bib25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.12066","article-title":"Pregnancy outcome following maternal exposure to statins: a multicentre prospective study","volume":"120","author":"Winterfeld","year":"2013","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2015.12.038_bib26","doi-asserted-by":"crossref","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: Cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2015.12.038_bib27","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/ajcn\/82.6.1155","article-title":"Maternal cholesterol in fetal development: transport of cholesterol from the maternal to the fetal circulation","volume":"82","author":"Woollett","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajog.2015.12.038_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2007.05.002","article-title":"Influence of maternal lipid profile on placental protein expression of LDLr and SR-BI","volume":"359","author":"Ethier-Chiasson","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajog.2015.12.038_bib29","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1161\/01.CIR.0000017634.00171.24","article-title":"Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project","volume":"105","author":"Pfeffer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2015.12.038_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00003088-200039060-00002","article-title":"Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events","volume":"39","author":"Hatanaka","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2015.12.038_bib31","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.placenta.2013.05.002","article-title":"The transfer of pravastatin in the dually perfused human placenta","volume":"34","author":"Zarek","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2015.12.038_bib32","doi-asserted-by":"crossref","first-page":"373.e1","DOI":"10.1016\/j.ajog.2013.05.038","article-title":"Transplacental transfer and distribution of pravastatin","volume":"209","author":"Nanovskaya","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.038_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2125.1990.tb03626.x","article-title":"Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects","volume":"29","author":"Singhvi","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2015.12.038_bib34","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0091270003257232","article-title":"Individual difference in the pharmacokinetics of a drug, pravastatin, in healthy subjects","volume":"43","author":"Ogawa","year":"2003","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ajog.2015.12.038_bib35","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.300.3.746","article-title":"Functional involvement of rat organic anion transporter 3 (rOAT3; Slc22a8) in the renal uptake of organic anions","volume":"300","author":"Hasegawa","year":"2002","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ajog.2015.12.038_bib36","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/bmc.3581","article-title":"Quantitative determination of pravastatin and its metabolite 3\u03b1-hydroxy pravastatin in plasma and urine of pregnant patients by LC-MS\/MS","volume":"30","author":"Zhang","year":"2016","journal-title":"Biomed Chromatogr"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2015.12.038_bib37","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/BF03216282","article-title":"Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase","volume":"40","author":"Pan","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2015.12.038_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2125.1990.tb03626.x","article-title":"Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects","volume":"29","author":"Singhvi","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2015.12.038_bib39","first-page":"159","article-title":"Diagnosis and management of preeclampsia and eclampsia. ACOG Practice bulletin no. 33","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.12.038_bib40","first-page":"1122","article-title":"Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815025867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815025867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:08:35Z","timestamp":1757588915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815025867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0002937815025867"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.12.038","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.12.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}